Opioid Addiction Prevention Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 5, 2017)
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to comply with certain requirements when prescribing opioids for the initial treatment of acute pain, such as a limit on the initial supply.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the requirements.
What just happenedOct 16, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Who’s behind it
- Introduced in HouseOct 5, 2017
- Oct 16, 2017Committee
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Federal Government Surveillance Subcommittee - Oct 6, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 5, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - Oct 5, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 5, 2017IntroReferralIntro-H
Introduced in House
- Oct 5, 2017IntroReferral1000
Introduced in House